iifl-logo-icon 1

Sequent Scientific Ltd Share Price

176
(0.36%)
Dec 24, 2024|03:29:56 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open174.55
  • Day's High178.99
  • 52 Wk High240.7
  • Prev. Close175.36
  • Day's Low172.6
  • 52 Wk Low 92.05
  • Turnover (lac)218.31
  • P/E218
  • Face Value2
  • Book Value43.79
  • EPS0.8
  • Mkt. Cap (Cr.)4,405.32
  • Div. Yield0
View All Historical Data
No Records Found

Sequent Scientific Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

174.55

Prev. Close

175.36

Turnover(Lac.)

218.31

Day's High

178.99

Day's Low

172.6

52 Week's High

240.7

52 Week's Low

92.05

Book Value

43.79

Face Value

2

Mkt Cap (₹ Cr.)

4,405.32

P/E

218

EPS

0.8

Divi. Yield

0

Sequent Scientific Ltd Corporate Action

6 Nov 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

27 Aug 2024

12:00 AM

AGM

Announcement Date: 27 Aug, 2024

arrow

Sequent Scientific Ltd NEWS AND UPDATE

Sequent Scientific jumps ~12% on ₹8,000 Crore merger with Viyash Life
27 Sep 2024|03:01 PM

Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sequent Scientific Ltd SHAREHOLDING SNAPSHOT

24 Dec, 2024|11:40 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 52.76%

Foreign: 52.76%

Indian: 0.00%

Non-Promoter- 16.44%

Institutions: 16.44%

Non-Institutions: 30.63%

Custodian: 0.16%

Share Price

Sequent Scientific Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

49.89

49.89

58.81

49.67

Preference Capital

0

0

0

0

Reserves

1,037.34

1,008.48

982.28

979.84

Net Worth

1,087.23

1,058.37

1,041.09

1,029.51

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

265.45

227.33

106

90.71

yoy growth (%)

16.77

114.45

16.85

-77.01

Raw materials

-108.86

-113.04

-79.37

-72.52

As % of sales

41.01

49.72

74.87

79.94

Employee costs

-22.41

-17.09

-11.85

-17.9

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

43.44

22.81

1.82

-15.16

Depreciation

-9.12

-8.95

-3.66

-3.25

Tax paid

-8.77

-1.47

-2.86

0

Working capital

33.97

-80.01

-110.8

56.46

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

16.77

114.45

16.85

-77.01

Op profit growth

58.69

-220.94

-39.83

-186.01

EBIT growth

65.64

1,156.67

-115.03

-154.81

Net profit growth

50.47

-94.74

-33,86,825

-100.11

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,369.73

1,420.91

1,412.82

1,361.62

1,179.24

Excise Duty

0

0

0

0

0

Net Sales

1,369.73

1,420.91

1,412.82

1,361.62

1,179.24

Other Operating Income

0

0

0

0

0

Other Income

10.96

6.39

10.85

8.36

10.09

Sequent Scientific Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,819

157.924,35,359.33863.290.745,123.6798.33

Divis Laboratories Ltd

DIVISLAB

5,782.35

84.511,55,255.325180.512,302513.62

Mankind Pharma Ltd

MANKIND

2,910.6

59.991,20,250.73634.4302,529.74269.23

Cipla Ltd

CIPLA

1,475.75

28.171,19,240.171,178.160.883,969.86360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,399.45

70.761,15,763.454600.822,376222.38

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Sequent Scientific Ltd

Management

Register Office

Registrar Office

Non-Exec. & Independent Dir.

Kausalya Santhanam

Joint Managing Director

Sharat Narasapur

Non-Exec & Non-Independent Dir

Neeraj Bharadwaj

Non-Exec & Non-Independent Dir

Gregory John Andrews

Non-Exec & Non-Independent Dir

Fabian Kausche

Chairman & Independent Directo

Kamal K Sharma

Non-Exec. & Independent Dir.

Milind Sarwate

Managing Director & CEO

N Rajaram

Non Executive Director

Hari Babu Bodepudi

Company Sec. & Compli. Officer

PHILLIP TROTT

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003.
Read More

Company FAQs

What is the Sequent Scientific Ltd share price today?

The Sequent Scientific Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹176 today.

What is the Market Cap of Sequent Scientific Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sequent Scientific Ltd is ₹4405.32 Cr. as of 24 Dec ‘24

What is the PE and PB ratio of Sequent Scientific Ltd?

The PE and PB ratios of Sequent Scientific Ltd is 218 and 3.94 as of 24 Dec ‘24

What is the 52 Week High and Low of Sequent Scientific Ltd?

The 52-week high/low is the highest and lowest price at which a Sequent Scientific Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sequent Scientific Ltd is ₹92.05 and ₹240.7 as of 24 Dec ‘24

What is the CAGR of Sequent Scientific Ltd?

Sequent Scientific Ltd's CAGR for 5 Years at 19.12%, 3 Years at 3.45%, 1 Year at 47.42%, 6 Month at 48.38%, 3 Month at -2.08% and 1 Month at -13.40%.

What is the shareholding pattern of Sequent Scientific Ltd?

The shareholding pattern of Sequent Scientific Ltd is as follows:
Promoters - 52.76 %
Institutions - 16.44 %
Public - 30.63 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp